Relationship of cognitive function and the acquisition of coping skills in computer assisted treatment for substance use disorders

Drug and Alcohol Dependence

Volumn 114, Issue 2-3, 2011, Pages 169-176

  Kiluk, Brian D ^a   Nich, Charla ^a   Carroll, Kathleen M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cognitive behavioral therapy; Cognitive function; Coping skills; Indirect effects

Indexed keywords

ARTICLE; COGNITION; COGNITIVE THERAPY; COMPUTER ASSISTED THERAPY; CONTROLLED STUDY; COPING BEHAVIOR; DIAGNOSTIC TEST ACCURACY STUDY; DRUG DEPENDENCE TREATMENT; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBSTANCE ABUSE;

ADAPTATION, PSYCHOLOGICAL; ADULT; COGNITION; COGNITIVE THERAPY; FEMALE; HUMANS; MALE; SUBSTANCE-RELATED DISORDERS; THERAPY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 79952703437     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.09.019     Document Type: Article

References (60)

1. Aharonovich E., Amrhein P.C., Bisaga A., Nunes E.V., Hasin D.S. Cognition, commitment language, and behavioral change among cocaine-dependent patients. Psychol. Addict. Behav. 2008, 22:557-562.
2. Aharonovich E., Brooks A.C., Nunes E.V., Hasin D.S. Cognitive deficits in marijuana users: effects on motivational enhancement therapy plus cognitive behavioral therapy treatment outcome. Drug Alcohol Depend. 2008, 95:279-283.
3. Aharonovich E., Hasin D.S., Brooks A.C., Liu X., Bisaga A., Nunes E.V. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend. 2006, 81:313-322.
4. Aharonovich E., Nunes E.V., Hasin D. Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug Alcohol Depend. 2003, 71:207-211.
5. Alterman A.I., Kushner H., Holahan J.M. Cognitive functioning and treatment outcome in alcoholics. J. Nerv. Ment. Dis. 1990, 178:494-499.
6. Aroian L.A. The probability function of the product of 2 normally distributed variables. Ann. Math. Stat. 1947, 18:265-271.
7. Bates M.E., Convit A. Neuropsychology and neuroimaging of alcohol and illicit drug abuse. The Assessment of Neuropsychological Functions in Psychiatric Disorders 1999, 373-445. American Psychiatric Publishing, Washington, DC. A. Calev (Ed.).
8. Bates M.E., Pawlak A.P., Tonigan J.S., Buckman J.F. Cognitive impairment influences drinking outcome by altering therapeutic mechanisms of change. Psychol. Addict. Behav. 2006, 20:241-253.
9. Bolla K., Ernst M., Kiehl K., Mouratidis M., Eldreth D., Contoreggi C., Matochik J., Kurian V., Cadet J., Kimes A., Funderburk F., London E. Prefrontal cortical dysfunction in abstinent cocaine abusers. J. Neuropsychiatry Clin. Neurosci. 2004, 16:456-464.
10. Carroll K.M. Relapse prevention as a psychosocial treatment approach: a review of controlled clinical trials. Exp. Clin. Psychopharmacol. 1996, 4:46-54.
11. Carroll K.M. A Cognitive-Behavioral Approach: Treating Cocaine Addiction 1998, NIDA, Rockville, Maryland.
12. Carroll K.M., Ball S.A., Martino S., Nich C., Babuscio T., Gordon M.A., Portnoy G.A., Rounsaville B.J. Computer-assisted cognitive-behavioral therapy for addiction. A randomized clinical trial of 'CBT4CBT'. Am. J. Psychiatry 2008, 165:881-888.
13. Carroll, K.M., Kiluk, B.D., Nich, C., Babuscio, T.A., Brewer, J., Potenza, M., Ball, S.A., Martino, S., Rounsaville, B.J., Lejuez, C.W., in press. Cognitive function and treatment response in a randomized clinical trial of computer-based training for cognitive behavioral therapy (CBT4CBT). Subst. Use Misuse.
14. Carroll K.M., Rounsaville B.J., Gordon L.T., Nich C., Jatlow P.M., Bisighini R.M., Gawin F.H. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch. Gen. Psychiatry 1994, 51:177-197.
15. Chung T., Langenbucher J., Labouvie E., Pandina R.J., Moos R.H. Changes in alcoholic patients' coping responses predict 12-month treatment outcomes. J. Consult. Clin. Psychol. 2001, 69:92-100.
16. Connors C.K. The Connors Continuous Performance Test II. Multi-Health Systems 2004, North Tonawanda, NY.
17. Cooper M.L., Russell M., Skinner J.B., Frone M.R., Mudar P. Stress and alcohol use: moderating effects of gender, coping, and alcohol expectancies. J. Abnorm. Psychol. 1992, 101:139-152.
18. Donovan D.M., Kivlahan D.R., Walker R.D. Clinical limitations of neuropsychological testing in predicting treatment outcome among alcoholics. Alcohol Clin. Exp. Res. 1984, 8:470-475.
19. Fals-Stewart W., O'Farrell T.J., Freitas T.T., McFarlin S.K., Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J. Consult. Clin. Psychol. 2000, 68:134-144.
20. Fals-Stewart W., Schafer J., Lucente S., Rustine T., Brown L. Neurobehavioral consequences of prolonged alcohol and substance abuse: a review of findings and treatment implications. Clin. Psychol. Rev. 1994, 14:755-778.
21. Freedman L.S., Schatzkin A. Sample size for studying intermediate endpoints within intervention trials of observational studies. Am. J. Epidemiol. 1992, 136:1148-1159.
22. Goldstein R.Z., Volkow N.D. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am. J. Psychiatry 2002, 159:1642-1652.
23. Gooding D.C., Burroghs S., Boutros N.N. Attention deficits in cocaine-dependent patients: converging behavioral and electrophysiological evidence. Psychiatry Res. 2008, 160:145-154.
24. Goodman L.A. On the exact variance of products. J. Am. Stat. Assoc. 1960, 55:708-713.
25. Grohman K., Fals-Stewart W. The detection of cognitive impairment among substance-abusing patients: the accuracy of the Neuropsychological Assessment Battery-Screening Module. Exp. Clin. Psychopharmacol. 2004, 12:200-207.
26. Hanson K.L., Luciana M., Sullwold K. Reward-related decision-making deficits and elevated impulsivity among MDMA and other drug users. Drug Alcohol Depend. 2008, 96:99-110.
27. Hayes A.F. Beyond Baron and Kenny: statistical medication analysis in the new milennium. Commun. Monogr. 2009, 76:408-420.
28. Jovanovski D., Erb S., Zakzanis K.K. Neurocognitive deficits in cocaine users: a quantitative review of the evidence. J. Clin. Exp. Neuropsychol. 2005, 27:189-204.
29. Joy S., Kaplan E., Fein D. Speed and memory in the WAIS-III Digit Symbol-Coding subtest across the adult lifespan. Arch. Clin. Neuropsychol. 2004, 19:759-767.
30. Kadden R.M., Cooney N.L., Getter H., Litt M.D. Matching alcoholics to coping skills or interactional therapies: Posttreatment results. J. Consult. Clin. Psychol. 1989, 57:698-704.
31. Kiluk, B.D., Nich, C., Babuscio, T., Carroll, K.M., 2010. Quantity vs. quality: acquisition of coping skills following computerized cognitive behavioral therapy for substance use disorders. Addiction, doi:10.1111/j.1360-0443.2010.03076.x.
32. Ledgerwood D.M., Alessi S.M., Phoenix N., Petry N.M. Behavioral assessment of impulsivity in pathological gamblers with and without substance use disorder histories versus healthy controls. Drug Alcohol Depend. 2009, 105:89-96.
33. Lejuez C.W., Aklin W.M., Zvolensky M.J., Pedulla C.M. Evaluation of the Balloon Analogue Risk Task (BART) as a predictor of adolescent real-world risk-taking behaviors. J. Adolesc. 2003, 26:475-479.
34. Lejuez C.W., Read J.P., Cahler C.W., Richards J.B., Ramsey S.E., Stuart G.L., Strong D.R., Brown R.A. Evaluation of a behavioral measure of risk taking: The Balloon Analogue Risk Task (BART). J. Exp. Psychol. Appl. 2002, 8:75-84.
35. Leland D.S., Paulus M.P. Increased risk-taking decision-making but not altered response to punishment in stimulant-using young adults. Drug Alcohol Depend. 2005, 78:83-90.
36. MacCallum R.C., Zhang S., Preacher K.J., Rucker D.D. On the practice of dichotomization of quantitative variables. Psychol. Methods 2002, 7:19-40.
37. MacKinnon D.P. Contrasts in multiple mediator models. Multivariate Applications in Substance Use Research: New Methods for New Questions 2000, 141-160. Erlbaum, Mahway, NJ. J.S. Rose, L. Chassin, C.C. Presson, S.J. Sherman (Eds.).
38. MacKinnon D.P., Fairchild A.J., Fritz M.S. Mediation analysis. Ann. Rev. Psychol. 2007, 58:593-614.
39. MacKinnon D.P., Fritz M.S., Williams J., Lockwood C.M. Distribution of the product confidence limits for the indirect effect: program PRODCLIN. Behav. Res. Methods 2007, 39:384-389.
40. MacKinnon D.P., Lockwood C.M., Williams J. Confidence limits for the indirect effect: distribution of the product and resampling methods. Multivariate Behav. Res. 2004, 39:99-128.
41. McKay J.R., Maisto S.A., O'Farrell T.J. Alcoholics' perceptions of factors in the onset and termination of relapses and the maintenance of abstinence: Results from a 30-month follow-up. Psychol. Addict. Behav. 1996, 10:167-180.
42. Meek P.S., Clark H.W., Solana V.L. Neurocognitive impairment: the unrecognized component of dual diagnosis in substance abuse treatment. J. Psychoactive Drugs 1989, 21:153-160.
43. Moeller F.G., Dougherty D.M. Impulsivity and substance abuse: what is the connection?. Addict. Disord. Their Treatment. 2002, 1:3-10.
44. Moeller F.G., Dougherty D.M., Barratt E.S., Schmitz J.M., Swann A.C., Grabowski J. The impact of impulsivity on cocaine use and retention in treatment. J. Subst. Abuse Treat. 2001, 21:193-198.
45. Monti P.M., Rohsenow D.J., Rubnis A.V., Niaura R.S., Sirota A.D., Colby S.M., Goddard R., Abrams D.B. Cue exposure with coping skills treatment for male alcoholics: a preliminary investigation. J. Consult. Clin. Psychol. 1993, 61:1011-1019.
46. Moos R.H. Theory-based active ingredients of effective treatments for substance use disorders. Drug Alcohol Depend. 2007, 88:109-121.
47. Morgenstern J., Bates M.E. Effects of executive function impairment on change processes and substance use outcomes in 12-step treatment. J. Stud. Alcohol. 1999, 60:846-855.
48. Morgenstern J., Longabaugh R. Cognitive-behavioral treatment for alcohol dependence: a review of the evidence for its hypothesized mechanisms of action. Addiction 2000, 95:1475-1490.
49. O'Malley S., Adamse M., Heaton R.K., Gawin F.H. Neuropsychological impairment in chronic cocaine abusers. Am. J. Drug Alcohol Abuse 1992, 18:131-144.
50. Passetti F., Clark L., Mehta M.A., Joyce E., King M. Neuropsychological predictors of clinical outcome in opiate addiction. Drug Alcohol Depend. 2008, 94:82-91.
51. Patton J.H., Stanford M.S., Barratt E.S. Factor structure of the Barratt impulsiveness scale. J. Clin. Psychol. 1995, 51:768-774.
52. Shipley W.C. Manual: Shipley-Institute of Living Scale 1967, Western Psychological Services, Los Angeles.
53. Sobel M.E. Asymptotic intervals for indirect effects in structural equations models. Sociological Methodology 1982, 290-312. Jossey-Bass, San Francisco. S. Leinhart (Ed.).
54. Spinella M. Normative data and a short form of the Barratt Impulsiveness Scale. Int. J. Neurosci. 2007, 117:359-368.
55. Verdejo-Garcia A.J., Lopez-Torrecillas F., Aguilar de Arcos F., Perez-Garcia M. Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis. Addict. Behav. 2005, 30:89-101.
56. Verdejo-Garcia A.J., Perales J.C., Perez-Garcia M. Cognitive impulsivity in cocaine and heroin polysubstance abusers. Addict. Behav. 2007, 32:950-966.
57. Vik P.W., Cellucci T., Jarchow A., Hedt J. Cognitive impairment in substance abuse. Psychiatr. Clin. North Am. 2004, 27:97-109. ix.
58. Wechsler D. Wechsler Adult Intelligence Scale-Third Edition (WAIS-III) 1997, Psychological Corporation, San Antonio.
59. Witkiewitz K., Marlatt G.A. Relapse prevention for alcohol and drug problems: that was Zen, this is Tao. Am. Psychol. 2004, 59:224-235.
60. Zachary R.A. Shipley Institute of Living Scale: Revised Manual 1986, Western Psychological Services, Los Angeles.